MedTrace Logo

Continuum Ceramic on Ceramic Bearing Post Market Clinical Follow-Up Study

NCT03343171 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 203

Last updated 2025-01-31

No results posted yet for this study

Summary

The primary objective of this study is to obtain implant survivorship and clinical outcome data for the commercially available Zimmer® Continuum™ Ceramic-on-Ceramic Bearing System when used in primary hip arthroplasty. This will be done by analysis of standard scoring systems, radiographs and adverse event records. Data will be used to monitor pain, mobility and survivorship, and to confirm the safety and efficacy of the Continuum Ceramic-on-Ceramic Bearing System.

Conditions

  • Osteoarthritis
  • Avascular Necrosis
  • Inflammatory Arthritis
  • Post-traumatic Arthritis

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Hassan Achakri · Zimmer Biomet

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-15
Primary Completion
2025-02-28
Completion
2025-09-30

Countries

  • Finland
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03343171 on ClinicalTrials.gov